Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Doxycycline Hyclate Patent Expiration

Doxycycline Hyclate is Used for treating or preventing infections caused by susceptible bacteria. It was first introduced by Pfizer Laboratories Div Pfizer Inc in its drug Vibramycin on Approved Prior to Jan 1, 1982. Other drugs containing Doxycycline Hyclate are Atridox, Vibra-Tabs, Acticlate Cap, Acticlate, Doryx Mpc, Periostat, Doryx, Lymepak. 66 different companies have introduced drugs containing Doxycycline Hyclate.


Doxycycline Hyclate Patents

Given below is the list of patents protecting Doxycycline Hyclate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Doryx Mpc US9446057 Controlled release doxycycline Dec 23, 2034 Mayne Pharma
Doryx Mpc US9295652 Controlled release doxycycline Oct 23, 2034 Mayne Pharma
Doryx Mpc US9511031 Controlled release doxycycline Oct 23, 2034 Mayne Pharma
Doryx US8715724 Tabletting process Feb 03, 2028 Mayne Pharma
Doryx Mpc US8715724 Tabletting process Feb 03, 2028 Mayne Pharma
Doryx US6958161 Modified release coated drug preparation Dec 15, 2022

(Expired)

 Mayne Pharma
Doryx Mpc US6958161 Modified release coated drug preparation Dec 15, 2022

(Expired)

 Mayne Pharma



Doxycycline Hyclate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Doxycycline Hyclate Generic API Manufacturers

Several generic applications have been filed for Doxycycline Hyclate. The first generic version for Doxycycline Hyclate was by Watson Laboratories Inc and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Amneal Eu Ltd and was approved on Dec 4, 2024.

Given below is the list of companies who have filed for Doxycycline Hyclate generic, along with the locations of their manufacturing plants worldwide.


1. ACELLA

Acella Pharmaceuticals Llc has filed for 1 generic for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Acella.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

tablet Prescription ORAL AB Mar 16, 2020


Manufacturing Plant Locations
New

Acella's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Acella as present at those locations.

Country City Firm Name
United States
Alpharetta Acella Pharmaceuticals, LLC





2. ACTAVIS ELIZABETH

Actavis Elizabeth Llc has filed for 4 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Actavis Elizabeth.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 75MG BASE

tablet, delayed release Prescription ORAL AB Dec 14, 2011
EQ 100MG BASE

tablet, delayed release Prescription ORAL AB Dec 14, 2011
EQ 200MG BASE

tablet, delayed release Prescription ORAL AB May 22, 2018
EQ 50MG BASE

tablet, delayed release Prescription ORAL AB May 22, 2018


Manufacturing Plant Locations
New

Actavis Elizabeth's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Actavis Elizabeth as present at those locations.

Country City Firm Name
United States
Elizabeth Actavis Elizabeth LLC, A Company of Teva





3. ACTAVIS LABS FL INC

Actavis Laboratories Fl Inc has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Actavis Labs Fl Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

tablet Prescription ORAL AB Feb 2, 1983
EQ 50MG BASE

capsule Prescription ORAL AB Oct 13, 1982





4. AJANTA PHARMA LTD

Ajanta Pharma Ltd has filed for 4 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Ajanta Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE

capsule Discontinued ORAL N/A Sep 24, 2018
EQ 100MG BASE

capsule Discontinued ORAL N/A Sep 24, 2018
EQ 150MG BASE

tablet Prescription ORAL AB Jun 1, 2020
EQ 75MG BASE

tablet Prescription ORAL AB Jun 1, 2020


Manufacturing Plant Locations
New

Ajanta Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Ajanta Pharma Ltd as present at those locations.

Country City Firm Name
India
Aurangabad Ajanta Pharma Ltd.





5. ALEMBIC

Alembic Pharmaceuticals Ltd has filed for 6 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Alembic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

tablet, delayed release Prescription ORAL AB Jan 3, 2022
EQ 50MG BASE

tablet Prescription ORAL AB Sep 14, 2021
EQ 20MG BASE

tablet Prescription ORAL AB Mar 3, 2020
EQ 150MG BASE

tablet, delayed release Prescription ORAL AB Jan 3, 2022
EQ 75MG BASE

tablet, delayed release Prescription ORAL AB Jan 3, 2022
EQ 200MG BASE

tablet, delayed release Prescription ORAL AB Jan 3, 2022


Manufacturing Plant Locations
New

Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.

Country City Firm Name
India
Vadodara Alembic Pharmaceuticals Ltd
Panchmahal Alembic Pharmaceuticals Limited (Units I and II)
Panchmahal Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals, Ltd
Panelav Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals Ltd (API Division, Karakhadi)





6. AMNEAL

Amneal Eu Ltd has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Amneal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

tablet Discontinued ORAL N/A Oct 24, 2022
EQ 100MG BASE/VIAL

injectable Prescription INJECTION AP Dec 4, 2024


Manufacturing Plant Locations
New

Amneal's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Amneal as present at those locations.

Country City Firm Name
United States
Paterson Amneal Pharmaceuticals, Llc
East Hanover Amneal Pharmaceuticals LLC
Glasgow Amneal Pharmaceuticals LLC
Bridgewater Amneal Complex Products Research LLC
Branchburg Amneal Pharmaceuticals, LLC
Hauppauge Amneal Pharmaceuticals of New York, LLC
Piscataway Amneal Pharmaceuticals, LLC
Brookhaven Amneal Pharmaceuticals of New York, LLC
India
Tal Bavla, Ahmedabad Amneal Pharmaceuticals Pvt. Ltd.
Ahmedabad Amneal Pharmaceuticals Private Ltd.
Hyderabad Amneal Oncology Private Limited
Matoda Amneal Pharmaceuticals Private Ltd.





7. AMNEAL PHARMS

Amneal Pharmaceuticals Holdings Gmbh has filed for 1 generic for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Amneal Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

capsule Prescription ORAL AB Jun 27, 2016





8. AMNEAL PHARMS CO

Amneal Pharmaceuticals Co Gmbh has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Amneal Pharms Co.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE

tablet Discontinued ORAL N/A Oct 6, 2017
EQ 75MG BASE

tablet Discontinued ORAL N/A Oct 6, 2017





9. APOTEX

Apotex Inc has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Apotex.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 75MG BASE

tablet Prescription ORAL AB Apr 15, 2019
EQ 150MG BASE

tablet Prescription ORAL AB Apr 15, 2019


Manufacturing Plant Locations
New

Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.

Country City Firm Name
United States
Weston Apotex Corp.
Canada
Toronto Apotex Inc.
Brantford Apotex Pharmachem Inc.
Etobicoke Apotex, Inc.
Winnipeg Apotex Fermentation Inc.
North York Apotex Inc.
Richmond Hill Apotex Inc.
India
Bangalore Apotex Pharmachem India Pvt Ltd.
Bangalore Apotex Research Private Limited - Bioequivalence Centre
Bengaluru Apotex Research Private Limited





10. AUROBINDO PHARMA USA

Aurobindo Pharma Usa Inc has filed for 1 generic for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE

tablet, delayed release Discontinued ORAL N/A Feb 8, 2012


Manufacturing Plant Locations
New

Aurobindo Pharma Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Usa as present at those locations.

Country City Firm Name
United States
East Windsor Aurobindo Pharma USA Inc





11. AVET LIFESCIENCES

Avet Lifesciences Ltd has filed for 1 generic for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Avet Lifesciences.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

tablet Discontinued ORAL N/A Nov 9, 2018





12. BAUSCH

Bausch Health Us Llc has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Bausch.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 75MG BASE

capsule, delayed release Discontinued ORAL N/A Dec 21, 2005
EQ 100MG BASE

capsule, delayed release Discontinued ORAL N/A Dec 21, 2005


Manufacturing Plant Locations
New

Bausch's manufacturing plants are situated in 2 countries - United States, Canada. Given below are the details of these plant locations as well as the firm names of Bausch as present at those locations.

Country City Firm Name
United States
Rancho Cucamonga Bausch and Lomb, Incorporated
Bridgewater Bausch Health Companies, Inc.
Greenville Bausch & Lomb Incorporated
Irvine Bausch and Lomb, Incorporated
Rochester Bausch Health Americas, Inc.
Petaluma Bausch Health Americas, Inc.
Woodruff Bausch & Lomb Inc
Rochester Bausch & Lomb Incorporated
Saint Louis Bausch & Lomb Inc
Lancaster Bausch & Lomb Incorporated
Wilmington Bausch & Lomb Incorporated
Manchester Bausch & Lomb, Inc.
Bridgewater Bausch and Lomb, Inc
Canada
Laval Bausch Health Companies Inc.
Steinbach Bausch Health Companies Inc.





13. CHANGZHOU PHARM

Changzhou Pharmaceutical Factory has filed for 1 generic for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Changzhou Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

tablet Prescription ORAL AB Oct 9, 2019


Manufacturing Plant Locations
New

Changzhou Pharm's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Changzhou Pharm as present at those locations.

Country City Firm Name
China
Changzhou Changzhou Pharmaceutical Factory





14. CHARTWELL

Chartwell Scheduled Llc has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Chartwell.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE

tablet Prescription ORAL AB Jul 27, 2021
EQ 100MG BASE

tablet Prescription ORAL AB Sep 11, 1984


Manufacturing Plant Locations
New

Chartwell's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Chartwell as present at those locations.

Country City Firm Name
United States
Congers Chartwell Life Sciences LLC
Carmel Chartwell Pharmaceuticals Carmel LLC
Richboro Chartwells Division of Compass Group / Commodities Locker
West Caldwell Chartwell Pharmaceuticals West Caldwell LLC
Congers Chartwell Pharmaceuticals LLC





15. CHARTWELL MOLECULAR

Chartwell Molecular Holdings Llc has filed for 1 generic for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Chartwell Molecular.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

(reference standard)

tablet Prescription ORAL AB Nov 10, 2005





16. DR REDDYS LABS SA

Dr Reddys Laboratories Sa has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Sa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE

tablet Prescription ORAL AB Jun 14, 2017
EQ 75MG BASE

tablet Prescription ORAL AB Jun 14, 2017





17. ENDO OPERATIONS

Endo Operations Ltd has filed for 1 generic for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Endo Operations.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE/VIAL

injectable Prescription INJECTION AP Dec 7, 2022





18. EPIC PHARMA LLC

Epic Pharma Llc has filed for 5 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

(reference standard)

tablet Prescription ORAL AB Nov 8, 1982
EQ 50MG BASE

tablet Prescription ORAL AB Oct 5, 1983
EQ 20MG BASE

tablet Prescription ORAL AB May 13, 2005
EQ 150MG BASE

tablet Prescription ORAL AB Dec 16, 2020
EQ 75MG BASE

tablet Prescription ORAL AB Dec 16, 2020





19. FRESENIUS KABI USA

Fresenius Kabi Usa Llc has filed for 2 different strengths of generic version for Doxycycline Hyclate. Out of these eq 100mg base/vial version comes by the name DOXY 100, eq 200mg base/vial version comes by the name DOXY 200. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE/VIAL

(reference standard)

injectable Prescription INJECTION AP Dec 9, 1983
EQ 200MG BASE/VIAL

(reference standard)

injectable Prescription INJECTION AP Dec 9, 1983


Manufacturing Plant Locations
New

Fresenius Kabi Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Fresenius Kabi Usa as present at those locations.

Country City Firm Name
United States
Bensenville Fresenius Kabi USA LLC (FK USA)
Skokie Fresenius Kabi USA LLC
North Andover Fresenius Kabi USA, LLC
Melrose Park Fresenius Kabi USA LLC
Melrose Park Fresenius Kabi USA, LLC
Lake Zurich Fresenius Kabi USA, LLC
Wilson Fresenius Kabi USA, LLC
Grand Island Fresenius Kabi USA, LLC





20. GLAND PHARMA LTD

Gland Pharma Ltd has filed for 1 generic for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Gland Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE/VIAL

injectable Prescription INJECTION AP Apr 12, 2023





21. HALSEY

Halsey Drug Co Inc has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Halsey.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE

capsule Discontinued ORAL N/A May 24, 1985
EQ 100MG BASE

capsule Discontinued ORAL N/A May 24, 1985


Manufacturing Plant Locations
New

Halsey's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Halsey as present at those locations.

Country City Firm Name
United States
Madison Halsey Foodservice





22. HEATHER

Heather Drug Co Inc has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Heather.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

capsule Discontinued ORAL N/A Dec 7, 1983
EQ 50MG BASE

capsule Discontinued ORAL N/A Dec 7, 1983


Manufacturing Plant Locations
New

Heather's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Heather as present at those locations.

Country City Firm Name
United States
New York Heather Lau
Roseville Heather L. Henderson, D.O.
Provo HEATHER R. HARRISON, D.O.
Kent Heather & Company For IBS LLC dba Heather's Tummy Care





23. HERITAGE

Heritage Pharmaceuticals Inc Dba Avet Pharmaceuticals Inc has filed for 5 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Heritage.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 75MG BASE

tablet, delayed release Prescription ORAL AB Apr 30, 2013
EQ 150MG BASE

tablet, delayed release Prescription ORAL AB Apr 30, 2013
EQ 100MG BASE

tablet, delayed release Prescription ORAL AB Apr 30, 2013
EQ 200MG BASE

(reference standard)

tablet, delayed release Prescription ORAL AB Nov 13, 2018
EQ 100MG BASE/VIAL

injectable Prescription INJECTION AP Jul 23, 2024


Manufacturing Plant Locations
New

Heritage's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Heritage as present at those locations.

Country City Firm Name
United States
Canfield Heritage Cooperative
Mc Cutchenville Heritage Cooperative, Inc
West Liberty Heritage Cooperative, Inc
New Philadelphia Heritage Cooperative
Ada Heritage Cooperative Inc
Springfield Heritage Cooperative, Inc
Woodsfield Heritage Cooperative
Van Nuys Heritage Candy Company, Inc.
Morgantown Heritage Animal Hospital
Sacramento Heritage Baking Company Inc.
Cairo Heritage Cooperative
London Heritage Cooperative Inc.
Minneapolis Heritage Deli Provisions, LLC
Waterford Heritage Cooperative
Fletcher Heritage Cooperative Inc
Kenton Heritage Cooperative
London Heritage Cooperative, Inc
South Burlington Heritage Aviation
Caldwell Heritage Country Store-Heritage Cooperative
Alger Heritage Cooperative
Urbana Heritage Cooperative Inc
West Mansfield Heritage Cooperative Inc.
Lisbon Heritage Cooperative, Inc.
De Graff Heritage Cooperative Inc
Beloit Heritage Cooperative
Chino Heritage #2
Richwood Heritage Cooperative, Inc
Vanlue Heritage Cooperative
Middlebury Heritage Acres
Dola Heritage Cooperative Inc
Fort Scott Heritage Acres Farm
Plain City Heritage Cooperative Inc.
Upper Sandusky Heritage Cooperative





24. HERITAGE PHARMA

Heritage Pharma Labs Inc has filed for 1 generic for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Heritage Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

tablet Discontinued ORAL N/A May 13, 2005


Manufacturing Plant Locations
New

Heritage Pharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Heritage Pharma as present at those locations.

Country City Firm Name
United States
East Brunswick Heritage Pharmaceuticals Inc
East Brunswick Heritage Pharmaceuticals, Inc. DBA AVET Pharmaceutical LABS





25. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Doxycycline Hyclate. All of these versions come by the name DOXYCYCLINE. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 200MG BASE/VIAL

injectable Discontinued INJECTION N/A Mar 9, 1988
EQ 100MG BASE/VIAL

injectable Discontinued INJECTION N/A Mar 9, 1988


Manufacturing Plant Locations
New

Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.

Country City Firm Name
United States
Dayton Hikma Injectables USA Inc
Cherry Hill Hikma Pharmaceuticals USA Inc.
Eatontown Hikma Pharmaceuticals USA, Inc.
Carlsbad Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Portugal
Terrugem Snt Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman Hikma Pharmaceuticals LLC





26. HIKMA INTL PHARMS

Hikma International Pharmaceuticals Llc has filed for 3 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Hikma Intl Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

tablet Prescription ORAL AB Jul 2, 2003
EQ 50MG BASE

capsule Prescription ORAL AB Nov 7, 1984
EQ 20MG BASE

capsule Discontinued ORAL N/A May 13, 2005





27. IMPAX LABS INC

Impax Laboratories Inc has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Impax Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 75MG BASE

tablet, delayed release Discontinued ORAL N/A Dec 28, 2010
EQ 100MG BASE

tablet, delayed release Discontinued ORAL N/A Dec 28, 2010





28. INTERPHARM

Interpharm Inc has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Interpharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

capsule Discontinued ORAL N/A Sep 2, 1988
EQ 50MG BASE

capsule Discontinued ORAL N/A Sep 2, 1988


Manufacturing Plant Locations
New

Interpharm's manufacturing plants are situated in 1 country - Czech Republic. Given below are the details of these plant locations as well as the firm names of Interpharm as present at those locations.

Country City Firm Name
Czech Republic
Prague 12 Interpharma Praha A.S.





29. KINDOS

Kindos Pharmaceuticals Co Ltd has filed for 1 generic for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Kindos.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE/VIAL

injectable Prescription INJECTION AP Oct 28, 2024


Manufacturing Plant Locations
New

Kindos's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Kindos as present at those locations.

Country City Firm Name
China
Chengdu Kindos Pharmaceuticals Co., Ltd.





30. LARKEN LABS

Larken Laboratories Inc has filed for 1 generic for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Larken Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

tablet Prescription ORAL AB Feb 28, 2006





31. LUPIN

Lupin Inc has filed for 8 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Lupin.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 60MG BASE

tablet, delayed release Discontinued ORAL N/A Aug 11, 2023
EQ 75MG BASE

tablet, delayed release Discontinued ORAL N/A Aug 11, 2023
EQ 80MG BASE

tablet, delayed release Discontinued ORAL N/A Aug 11, 2023
EQ 100MG BASE

tablet, delayed release Discontinued ORAL N/A Aug 11, 2023
EQ 120MG BASE

tablet, delayed release Discontinued ORAL N/A Aug 11, 2023
EQ 50MG BASE

tablet, delayed release Discontinued ORAL N/A Aug 11, 2023
EQ 150MG BASE

tablet, delayed release Discontinued ORAL N/A Aug 11, 2023
EQ 200MG BASE

tablet, delayed release Discontinued ORAL N/A Aug 11, 2023


Manufacturing Plant Locations
New

Lupin's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Lupin as present at those locations.

Country City Firm Name
India
Navi Mumbai LUPIN LIMITED
Mandideep Lupin Limited (Unit II)
Vasco Da Gama Lupin Limited
Pithampur Lupin Limited
Aurangabad Lupin Ltd.
Pirangut Lupin Limited
Pithampur Lupin Limited (Unit 1)
Tarapur, Thane Lupin Limited
Anakapalli District Lupin Manufacturing Solutions Limited
Mumbai Lupin Limited
Mandideep Lupin Limited
Dabhasa LUPIN MANUFACTURING SOLUTIONS LIMITED
Nagpur Lupin Limited
Pune Lupin Bioresearch Center
United States
Baltimore Lupin Pharmaceuticals Inc.
Coral Springs Lupin Research Inc





32. LUPIN LTD

Lupin Ltd has filed for 3 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Lupin Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 75MG BASE

tablet Prescription ORAL AB Sep 27, 2017
EQ 150MG BASE

tablet Prescription ORAL AB Sep 27, 2017
EQ 100MG BASE/VIAL

injectable Prescription INJECTION AP Mar 14, 2024


Manufacturing Plant Locations
New

Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.

Country City Firm Name
India
Aurangabad Lupin Ltd.





33. MUTUAL PHARM

Mutual Pharmaceutical Co Inc has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Mutual Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

capsule Discontinued ORAL N/A Jan 28, 1983
EQ 50MG BASE

capsule Prescription ORAL AB Jul 10, 1986





34. MYLAN

Mylan Pharmaceuticals Inc has filed for 1 generic for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Mylan.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

tablet Prescription ORAL AB Feb 15, 1983


Manufacturing Plant Locations
New

Mylan's manufacturing plants are situated in 4 countries - United States, India, Canada, Ireland. Given below are the details of these plant locations as well as the firm names of Mylan as present at those locations.

Country City Firm Name
United States
Rockford Mylan Institutional, Inc.
Santa Barbara Mylandon LLC dba Debbie s Delights Santa Barbara Baking Co.
San Carlos Mylan Pharmaceuticals Inc.
Morgantown MYLAN CONSUMER HEALTHCARE Inc.
Morgantown Mylan Specialty, L.P.
Saint Albans Mylan Technologies, Inc.
Greensboro Mylan Pharmaceuticals Inc
India
Hyderabad Mylan Laboratories Limited
Sarigam Mylan Laboratories Limited
Bangalore Mylan Laboratories Limited
Anekal Taluk, Bangalore Mylan Laboratories Limited
Pithampur, District Dhar Mylan Laboratories Limited
Sinnar Mylan Laboratories Limited
Hosur Mylan Laboratories Limited
Aurangabad Mylan Laboratories Limited (FDF-2)
Canada
Etobicoke Mylan Pharmaceuticals ULC
Ireland
Inverin Mylan Teoranta





35. MYLAN LABS LTD

Mylan Laboratories Ltd has filed for 1 generic for Doxycycline Hyclate. This eq 100mg base/vial version comes by the name DOXYCYCLINE. Given below are the details of the strengths of this generic introduced by Mylan Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE/VIAL

injectable Prescription INJECTION AP Aug 21, 2012





36. NESHER PHARMS

Nesher Pharmaceuticals Usa Llc has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Nesher Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

capsule Discontinued ORAL N/A Nov 22, 2021
EQ 50MG BASE

capsule Discontinued ORAL N/A Nov 22, 2021





37. NOSTRUM LABS INC

Nostrum Laboratories Inc has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Nostrum Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

tablet Discontinued ORAL N/A Apr 15, 2024
EQ 50MG BASE

capsule Discontinued ORAL N/A Dec 10, 2020





38. NOVEL LABS INC

Novel Laboratories Inc has filed for 1 generic for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Novel Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

tablet Prescription ORAL AB Sep 6, 2017





39. ORYZA

Oryza Pharmaceuticals Inc has filed for 1 generic for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Oryza.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

tablet Discontinued ORAL N/A Mar 10, 2021


Manufacturing Plant Locations
New

Oryza's manufacturing plants are situated in 1 country - Japan. Given below are the details of these plant locations as well as the firm names of Oryza as present at those locations.

Country City Firm Name
Japan
Ichinomiya Oryza Oil & Fat Chemical Co., Ltd.





40. PAR PHARM

Par Pharmaceutical Inc has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Par Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

capsule Discontinued ORAL N/A Dec 22, 1983
EQ 50MG BASE

capsule Discontinued ORAL N/A Oct 19, 1984


Manufacturing Plant Locations
New

Par Pharm's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Par Pharm as present at those locations.

Country City Firm Name
United States
Stratford Par Pharmaceutical Inc.
Hauppauge Par Pharmaceuticals





41. PLIVA

Pliva Inc has filed for 1 generic for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Pliva.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

capsule, coated pellets Discontinued ORAL N/A Jun 30, 1992


Manufacturing Plant Locations
New

Pliva's manufacturing plants are situated in 3 countries - Croatia, United States, Czech Republic. Given below are the details of these plant locations as well as the firm names of Pliva as present at those locations.

Country City Firm Name
Croatia
Zagreb PLIVA Hrvatska d.o.o.
Brdovec Pliva Hrvatska d.o.o.
United States
East Hanover Pliva, Inc.
Czech Republic
Brno PLIVA-Lachema a.s.





42. PRAXGEN

Praxgen Pharmaceuticals Llc has filed for 1 generic for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Praxgen.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

tablet Discontinued ORAL N/A Mar 30, 2022


Manufacturing Plant Locations
New

Praxgen's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Praxgen as present at those locations.

Country City Firm Name
United States
Monmouth Junction Praxgen Pharmaceuticals, LLC





43. PRINSTON INC

Prinston Pharmaceutical Inc has filed for 3 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Prinston Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 200MG BASE

tablet, delayed release Prescription ORAL AB Nov 15, 2016
EQ 150MG BASE

tablet, delayed release Prescription ORAL AB Nov 15, 2016
EQ 50MG BASE

tablet, delayed release Prescription ORAL AB Feb 19, 2019





44. PVT FORM

Private Formulations Inc has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Pvt Form.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE

capsule Discontinued ORAL N/A Jul 24, 1986
EQ 100MG BASE

capsule Discontinued ORAL N/A Jul 24, 1986





45. RACHELLE

Rachelle Laboratories Inc has filed for 1 generic for Doxycycline Hyclate. This eq 100mg base/vial version comes by the name DOXYCHEL HYCLATE. Given below are the details of the strengths of this generic introduced by Rachelle.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE/VIAL

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982





46. RANBAXY

Ranbaxy Pharmaceuticals Inc has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Ranbaxy.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE

capsule Discontinued ORAL N/A Dec 23, 1983
EQ 100MG BASE

capsule Discontinued ORAL N/A Dec 23, 1983


Manufacturing Plant Locations
New

Ranbaxy's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Ranbaxy as present at those locations.

Country City Firm Name
United States
Princeton Ranbaxy Inc.





47. RISING

Rising Pharma Holding Inc has filed for 6 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Rising.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

tablet, delayed release Discontinued ORAL N/A Dec 28, 2010
EQ 75MG BASE

tablet Discontinued ORAL N/A Oct 5, 2020
EQ 80MG BASE

tablet, delayed release Discontinued ORAL N/A Apr 29, 2016
EQ 200MG BASE

tablet, delayed release Discontinued ORAL N/A May 19, 2016
EQ 50MG BASE

tablet, delayed release Discontinued ORAL N/A May 23, 2016
EQ 150MG BASE

tablet Discontinued ORAL N/A Oct 5, 2020


Manufacturing Plant Locations
New

Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.

Country City Firm Name
United States
Phoenix Rising Sun Farms Inc
Fort Bragg Rising Tide Sea Vegetables
Saddle Brook Rising Pharmaceuticals, Inc.
Decatur Rising Pharma Holdings, Inc
Livingston Risingsun Iodine Products Corp.
East Brunswick Rising Pharma Holding, Inc.
Mount Morris Rising Creek Bakery LLC
Rising Sun Rising Sun Veterinary Clinic
Flagstaff Rising High Enterprises, LLC (DBA RisingHy)
Mexico
Pueblo San Clemente RISING FARMS SAPI DE CV
India
Ahmedabad Rising Retina Clinic





48. SLATE RUN PHARMA

Slate Run Pharmaceuticals Llc has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Slate Run Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE/VIAL

injectable Prescription INJECTION AP Jun 21, 2024
EQ 200MG BASE/VIAL

injectable Prescription INJECTION AP Jun 21, 2024





49. STRIDES PHARMA

Strides Pharma Global Pte Ltd has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Strides Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

tablet Discontinued ORAL N/A Apr 7, 1986
EQ 50MG BASE

capsule Discontinued ORAL N/A Mar 29, 1982


Manufacturing Plant Locations
New

Strides Pharma's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Strides Pharma as present at those locations.

Country City Firm Name
United States
East Brunswick Strides Pharma Inc.
Chestnut Ridge Strides Pharma, Inc.
India
Puducherry Strides Pharma Science Limited
Bangalore Strides Pharma Science Limited





50. SUN PHARM INDUSTRIES

Sun Pharmaceutical Industries Inc has filed for 3 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Sun Pharm Industries.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

tablet Prescription ORAL AB Jul 10, 1986
EQ 50MG BASE

capsule Prescription ORAL AB Jul 10, 1986
EQ 20MG BASE

tablet Prescription ORAL AB May 13, 2005





51. SUPERPHARM

Superpharm Corp has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Superpharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

tablet Discontinued ORAL N/A Feb 20, 1985
EQ 50MG BASE

capsule Discontinued ORAL N/A Oct 31, 1984





52. TEVA

Teva Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Doxycycline Hyclate. All of these versions come by the name DOXY-LEMMON. Given below are the details of the strengths of this generic introduced by Teva.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

tablet Discontinued ORAL N/A Mar 15, 1985
EQ 50MG BASE

capsule Discontinued ORAL N/A Aug 23, 1984


Manufacturing Plant Locations
New

Teva's manufacturing plants are situated in 6 countries - United States, India, Canada, Czech Republic, Ireland, Israel. Given below are the details of these plant locations as well as the firm names of Teva as present at those locations.

Country City Firm Name
United States
Horsham Teva Branded Pharmaceutical Products R&D
Malvern Teva Branded Pharmaceutical Products R&D, Inc.
Fort Dodge TEVA Animal Health Inc
Miami Teva Branded Pharmaceutical Products R & D, Inc.
India
Gajraula, Amroha Teva API India Private Ltd.
Bhind Teva API India Ltd- Malanpur
Canada
Markham Teva Canada Limited
Scarborough Teva Canada Limited
Stouffville Teva Canada Limited
Czech Republic
Opava Teva Czech Industries s.r.o.
Ireland
Dundalk Teva Laboratories Ireland Ltd
Israel
Kiryat-Shmona TEVA Medical Ltd.





53. TORRENT

Torrent Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Torrent.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 75MG BASE

tablet Discontinued ORAL N/A Apr 15, 2024
EQ 150MG BASE

tablet Discontinued ORAL N/A Apr 15, 2024


Manufacturing Plant Locations
New

Torrent's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Torrent as present at those locations.

Country City Firm Name
India
Pithampur Torrent Pharmaceuticals Limited
Gandhi Nagar Torrent Pharmaceuticals Limited
Bharuch Torrent Pharmaceuticals Limited
Indrad Torrent Pharmaceuticals Limited
Thanam Torrent Pharmaceuticals Limited
United States
Basking Ridge Torrent Pharma Inc.
Kalamazoo Torrent Pharma Inc.





54. WARNER CHILCOTT

Warner Chilcott Div Warner Lambert Co has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Warner Chilcott.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

capsule Discontinued ORAL N/A Dec 5, 1985
EQ 50MG BASE

capsule Discontinued ORAL N/A Dec 5, 1985


Manufacturing Plant Locations
New

Warner Chilcott's manufacturing plants are situated in 2 countries - United States, Germany. Given below are the details of these plant locations as well as the firm names of Warner Chilcott as present at those locations.

Country City Firm Name
United States
Rockaway Warner Chilcott US LLC
Manati Warner Chilcott Company LLC
Norwich Warner Chilcott Pharmaceuticals, Inc.
Germany
Weiterstadt Warner Chilcott Deutschland GmbH





55. WATSON LABS

Watson Laboratories Inc has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Watson Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

tablet Discontinued ORAL N/A Mar 31, 1983
EQ 50MG BASE

tablet Discontinued ORAL N/A Mar 31, 1983





56. WEST-WARD PHARMS INT

West-ward Pharmaceuticals International Ltd has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by West-ward Pharms Int.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 200MG BASE/VIAL

injectable Prescription INJECTION AP Feb 16, 1989
EQ 100MG BASE/VIAL

injectable Prescription INJECTION AP Feb 16, 1989





57. ZHEJIANG YONGTAI

Zhejiang Yongtai Pharmaceutical Co Ltd has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Zhejiang Yongtai.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

capsule Discontinued ORAL N/A Mar 31, 2020
EQ 50MG BASE

capsule Discontinued ORAL N/A Mar 31, 2020


Manufacturing Plant Locations
New

Zhejiang Yongtai's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Zhejiang Yongtai as present at those locations.

Country City Firm Name
China
Linhai Zhejiang Yongtai Pharmaceutical Co. Ltd





58. ZYDUS LIFESCIENCES

Zydus Lifesciences Ltd has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Zydus Lifesciences.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

capsule Prescription ORAL AB May 31, 2018
EQ 50MG BASE

capsule Prescription ORAL AB May 31, 2018


Manufacturing Plant Locations
New

Zydus Lifesciences's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Zydus Lifesciences as present at those locations.

Country City Firm Name
India
Jarod Zydus Lifesciences Limited
District Solan Zydus Lifesciences Limited
Ahmedabad Zydus Lifesciences Limited
Dabhasa Zydus Lifesciences Limited
Moraiya, Ahmedabad Zydus Lifesciences Limited
Thane Zydus Lifesciences Limited
Matoda Zydus Lifesciences Limited
Ahmedabad ZYDUS LIFESCIENCES LIMITED
Ankleshwar Zydus Lifesciences Limited





59. ZYDUS PHARMS

Zydus Pharmaceuticals Usa Inc has filed for 5 different strengths of generic version for Doxycycline Hyclate. Out of these eq 100mg base/vial version comes by the name DOXYCYCLINE, eq 200mg base/vial version comes by the name DOXYCYCLINE. Given below are the details of the strengths of this generic introduced by Zydus Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE/VIAL

(reference standard)

injectable Prescription INJECTION AP Sep 28, 2017
EQ 200MG BASE/VIAL

injectable Prescription INJECTION AP Sep 28, 2017
EQ 75MG BASE

tablet, delayed release Discontinued ORAL N/A Dec 21, 2018
EQ 100MG BASE

tablet, delayed release Discontinued ORAL N/A Dec 21, 2018
EQ 150MG BASE

tablet, delayed release Discontinued ORAL N/A Dec 21, 2018